These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 29479708)
1. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Lokhandwala PM; O'Neal A; Patel EU; Brunker PAR; Gehrie EA; Zheng G; Kickler TS; Ness PM; Tobian AAR Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708 [TBL] [Abstract][Full Text] [Related]
2. The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours. Green L; Backholer L; Wiltshire M; Platton S; Stanworth SJ; Cardigan R Transfusion; 2016 Jun; 56(6):1356-61. PubMed ID: 27019386 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours. Soundar EP; Reyes M; Korte L; Bracey A Blood Transfus; 2018 Sep; 16(5):443-446. PubMed ID: 29106354 [TBL] [Abstract][Full Text] [Related]
4. Extending the post-thaw viability of cryoprecipitate. Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705 [TBL] [Abstract][Full Text] [Related]
5. Hemostatic characteristics of thawed, pooled cryoprecipitate stored for 35 days at refrigerated and room temperatures. Fenderson JL; Meledeo MA; Rendo MJ; Peltier GC; McIntosh CS; Davis KW; Corley JB; Cap AP Transfusion; 2019 Apr; 59(S2):1560-1567. PubMed ID: 30980741 [TBL] [Abstract][Full Text] [Related]
6. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. Yazer MH; Triulzi DJ; Hassett AC; Kiss JE Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046 [TBL] [Abstract][Full Text] [Related]
7. Can storage of thawed cryoprecipitate be extended to more than six hours? Saxena S; Odono V; Francis RB; Endahl GL; Shulman IA Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291 [TBL] [Abstract][Full Text] [Related]
8. Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20-24°C for up to 24 h. Sheffield WP; Bhakta V; Jenkins C Vox Sang; 2016 Jan; 110(1):12-9. PubMed ID: 26178178 [TBL] [Abstract][Full Text] [Related]
9. Effects of pathogen reduction technology and storage duration on the ability of cryoprecipitate to rescue induced coagulopathies in vitro. Thomas KA; Shea SM; Spinella PC Transfusion; 2021 Jun; 61(6):1943-1954. PubMed ID: 33755208 [TBL] [Abstract][Full Text] [Related]
10. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure. Hoffman M; Jenner P Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369 [TBL] [Abstract][Full Text] [Related]
11. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems. Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126 [TBL] [Abstract][Full Text] [Related]
12. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C. Spivey MA; Jeter EK; Lazarchick J; Kizer J; Spivey LB Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439 [TBL] [Abstract][Full Text] [Related]
13. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257 [TBL] [Abstract][Full Text] [Related]
14. Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma. Hornsey VS; Krailadsiri P; MacDonald S; Seghatchian J; Williamson LM; Prowse CV Br J Haematol; 2000 Jun; 109(3):665-70. PubMed ID: 10886222 [TBL] [Abstract][Full Text] [Related]
15. Stability of von Willebrand factor and factor VIII in canine cryoprecipitate under various conditions of storage. Stokol T; Parry BW Res Vet Sci; 1995 Sep; 59(2):152-5. PubMed ID: 8525105 [TBL] [Abstract][Full Text] [Related]
16. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Serrano K; Scammell K; Weiss S; Culibrk B; Levin E; Gyöngyössy-Issa M; Devine DV Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287 [TBL] [Abstract][Full Text] [Related]
17. The possible advantages of cryoprecipitate prepared from fresh frozen plasma from blood stored for 24 hours. Philip J; Kumarage S; Chatterjee T; Kumar S; Mallhi R Lab Med; 2014; 45(2):111-5. PubMed ID: 24868990 [TBL] [Abstract][Full Text] [Related]
18. Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate. Stanford S; Roy A; Cecil T; Hegener O; Schulz P; Turaj A; Lim S; Arbuthnot E PLoS One; 2023; 18(8):e0290571. PubMed ID: 37647278 [TBL] [Abstract][Full Text] [Related]
19. Analysis of prolonged storage on coagulation Factor (F)V, FVII, and FVIII in thawed plasma: is it time to extend the expiration date beyond 5 days? Tholpady A; Monson J; Radovancevic R; Klein K; Bracey A Transfusion; 2013 Mar; 53(3):645-50. PubMed ID: 22803679 [TBL] [Abstract][Full Text] [Related]
20. Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate. Drinkhouse M; Brooks MB; Stefanovski D; Marryott K; Callan MB J Vet Intern Med; 2019 Jan; 33(1):124-131. PubMed ID: 30548342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]